Literature DB >> 16864611

Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.

Marcelle D Smit1, Pascal F H M Van Dessel, Michiel Rienstra, Wybe Nieuwland, Ans C P Wiesfeld, Eng S Tan, Rutger L Anthonio, Dirk J Van Veldhuisen, Isabelle C Van Gelder.   

Abstract

AIMS: Atrial fibrillation (AF) is often present in patients with left ventricular dysfunction who receive an implantable cardioverter-defibrillator (ICD). The purpose of this study was to investigate whether AF is associated with appropriate shocks and cardiovascular mortality in primary prevention ICD patients with left ventricular dysfunction. METHODS AND
RESULTS: We included 80 primary prevention ICD patients with left ventricular dysfunction and compared the outcome between patients with a history of AF (n=29) and patients with no history of AF (n=51). The primary endpoint was occurrence of appropriate shocks. Secondary endpoints were: (1) the composite of cardiovascular mortality/appropriate shocks; and (2) inappropriate shocks. During follow-up (median 8 months, range 1-60), patients with a history of AF more often received appropriate shocks than patients with no history of AF (24 vs. 6%, P=0.03). The composite endpoint of cardiovascular mortality/appropriate shocks was also more likely to occur in patients with a history of AF (34 vs. 12%, P=0.02). History of AF predicted appropriate shocks (HR 6.9, 95% CI 1.7-27.5, P=0.006) and the composite endpoint of cardiovascular mortality/appropriate shocks (adjusted HR 5.1, 95% CI 1.7-15.1, P=0.003). There were no differences in occurrence of inappropriate shocks.
CONCLUSION: Our study demonstrates that history of AF is associated with increased risk of appropriate shocks and cardiovascular mortality in primary prevention ICD patients with left ventricular dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16864611     DOI: 10.1093/europace/eul081

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication: male gender and AF in primary ICD prophylaxis.

Authors:  T Deneke; T Lawo; J Reinecke; C Buttler; P H Grewe; D-I Shin; B Gerritse; A Mügge; B Lemke; A Kloppe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

2.  Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II.

Authors:  Emily P Zeitler; Sana M Al-Khatib; Daniel J Friedman; Joo Yoon Han; Jeanne E Poole; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Arthur J Moss; Kerry L Lee; Paul Dorian; Riccardo Cappato; Alan H Kadish; Peter J Kudenchuk; Daniel B Mark; Lurdes Y T Inoue; Gillian D Sanders
Journal:  J Cardiovasc Electrophysiol       Date:  2017-08-23

3.  Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

4.  Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.

Authors:  Usman Mustafa; Parinita Dherange; Rohit Reddy; Joseph DeVillier; Jessica Chong; Alarozia Ihsan; Ryan Jones; Narendra Duddyala; Pratap Reddy; Paari Dominic
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

5.  Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study.

Authors:  Ari Pelli; M Juhani Junttila; Tuomas V Kenttä; Simon Schlögl; Markus Zabel; Marek Malik; Tobias Reichlin; Rik Willems; Marc A Vos; Markus Harden; Tim Friede; Christian Sticherling; Heikki V Huikuri
Journal:  Europace       Date:  2022-05-03       Impact factor: 5.486

6.  Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.

Authors:  Shaun Giancaterino; Marin Nishimura; Ulrika Birgersdotter-Green; Kurt S Hoffmayer; Frederick T Han; Farshad Raissi; Gordon Ho; David Krummen; Gregory K Feld; Jonathan C Hsu
Journal:  Pacing Clin Electrophysiol       Date:  2020-05-02       Impact factor: 1.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.